1,3,5-triaza-7-phosphaadamantane and tristearin

1,3,5-triaza-7-phosphaadamantane has been researched along with tristearin in 1 studies

Compound Research Comparison

Studies (1,3,5-triaza-7-phosphaadamantane)	Trials (1,3,5-triaza-7-phosphaadamantane)	Recent Studies (post-2010) (1,3,5-triaza-7-phosphaadamantane)	Studies (tristearin)	Trials (tristearin)	Recent Studies (post-2010) (tristearin)
44	0	33	134	2	83

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bergamini, P; Campioni, M; Cortesi, R; Costenaro, A; Drechsler, M; Esposito, E; Marvelli, L; Pinotti, M; Ravani, L	1

Other Studies

1 other study(ies) available for 1,3,5-triaza-7-phosphaadamantane and tristearin

Article	Year
Long-chain cationic derivatives of PTA (1,3,5-triaza-7-phosphaadamantane) as new components of potential non-viral vectors. International journal of pharmaceutics, 2012, Jul-15, Volume: 431, Issue:1-2 Topics: Adamantane; Animals; Cell Line; Cell Proliferation; Cricetinae; DNA; Genetic Vectors; Humans; K562 Cells; Nanoparticles; Organophosphorus Compounds; Particle Size; Surface Properties; Transfection; Triglycerides	2012

Article

Year

Long-chain cationic derivatives of PTA (1,3,5-triaza-7-phosphaadamantane) as new components of potential non-viral vectors.

International journal of pharmaceutics, 2012, Jul-15, Volume: 431, Issue:1-2

Topics: Adamantane; Animals; Cell Line; Cell Proliferation; Cricetinae; DNA; Genetic Vectors; Humans; K562 Cells; Nanoparticles; Organophosphorus Compounds; Particle Size; Surface Properties; Transfection; Triglycerides

2012